Swiss pharmaceutical giant Novartis believes the anti-malaria drug hydroxychloroquine offers one of the best hopes to combat coronavirus and has donated 130 million doses as part of the pandemic response.Swissinfo
Swiss pharmaceutical giant Novartis believes the anti-malaria drug hydroxychloroquine offers one of the best hopes to combat coronavirus and has donated 130 million doses as part of the pandemic response.Swissinfo
No comments:
Post a Comment